Advertisement
Product › Details
ACTCellerate™ human progenitor cell line
![]() |
Next higher product group | cell line/system (recombinant protein production)_o |
![]() |
Status | 2009-07-09 sales start |
![]() |
Organisation | Millipore Corporation (NYSE: MIL) |
| Today | Merck Millipore Division (EMD Millipore Division) | |
| Group | Merck (DE) (Group) | |
![]() |
Source | BioTime, Inc.. (7/9/09). "Press Release: BioTime Announces Stem Cell Co-marketing Agreement with Millipore. Millipore to Distribute BioTime’s Novel ACTCellerate Human Progenitor Cells". |
Record changed: 2011-11-25 |
Advertisement
More documents for cell line/system (recombinant protein production)
- [1] BIOPRO Baden-Württemberg GmbH. (3/11/13). "News: Trenzyme – Optimal Expression of Recombinant Proteins"....
- [2] Selexis S.A.. (2/20/13). "Press Release: Selexis Announces Expansion of R&D License Agreement with Amgen. Expansion to Include the Selexis SURE CHO-M Cell Line". Geneva....
- [3] ProBioGen AG. (11/12/12). "Press Release: ProBioGen Launches Unique Portfolio of Engineered High-performance Cell Lines for Biopharmaceutical Manufacturing". Berlin....
- [4] Selexis S.A.. (6/27/12). "Press Release: Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic. Lubris Achieves Over Gram per Liter of Recombinant Human Lubricin Using Selexis SUREtechnology Platform". Geneva....
- [5] Selexis S.A.. (5/15/12). "Press Release: Adienne Pharma & Biotech Signs Service Agreement with Selexis for the Development of a Novel Fully Human Mini-Antibody". Geneva....
- [6] Artes Biotechnology GmbH. (4/24/12). "Press Release: Artes Announces a Strategic Collaboration Deal for Vaccine Development". Langenfeld....
- [7] ProBioGen AG. (3/15/12). "Press Release: Ceva Takes Commercial License for ProBioGen’s AGE1.CR Cell Line for Viral Vaccine Production". Libourne & Berlin....
- [8] Norgenta Norddeutsche Life Science Agentur. (9/2/11). "Pressemitteilung: Fraunhofer-Einrichtung und neue Gesellschaft für industrielle Zelltechnik stärken den Wissenschafts- und Wirtschaftsstandort Schleswig-Holstein". Lübeck....
- [9] Boehringer Ingelheim. (8/10/11). "Press Release: Boehringer Ingelheim Licenses ProBioGen’s Novel GlymaxX Technology". Ingelheim & Berlin....
- [10] ProBioGen AG. (5/17/11). "Press Release: ProBioGen and Life Technologies Present Freedom CHO-S Platform, a Royalty-free New cGMP Cell Line Development Kit". Berlin....
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg)









![Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)